179 related articles for article (PubMed ID: 20029944)
41. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans.
Fustinoni S; Soleo L; Warholm M; Begemann P; Rannug A; Neumann HG; Swenberg JA; Vimercati L; Colombi A
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1082-90. PubMed ID: 12376511
[TBL] [Abstract][Full Text] [Related]
42. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
McGrath M; Michaud D; De Vivo I
BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
[TBL] [Abstract][Full Text] [Related]
43. Association of metabolic gene polymorphisms with tobacco consumption in healthy controls.
Smits KM; Benhamou S; Garte S; Weijenberg MP; Alamanos Y; Ambrosone C; Autrup H; Autrup JL; Baranova H; Bathum L; Boffetta P; Bouchardy C; Brockmoller J; Butkiewicz D; Cascorbi I; Clapper ML; Coutelle C; Daly AK; Muzi G; Dolzan V; Duzhak TG; Farker K; Golka K; Haugen A; Hein DW; Hildesheim A; Hirvonen A; Hsieh LL; Ingelman-Sundberg M; Kalina I; Kang D; Katoh T; Kihara M; Ono-Kihara M; Kim H; Kiyohara C; Kremers P; Lazarus P; Le Marchand L; Lechner MC; London S; Manni JJ; Maugard CM; Morgan GJ; Morita S; Nazar-Stewart V; Kristensen VN; Oda Y; Parl FF; Peters WH; Rannug A; Rebbeck T; Pinto LF; Risch A; Romkes M; Salagovic J; Schoket B; Seidegard J; Shields PG; Sim E; Sinnett D; Strange RC; Stucker I; Sugimura H; To-Figueras J; Vineis P; Yu MC; Zheng W; Pedotti P; Taioli E
Int J Cancer; 2004 Jun; 110(2):266-70. PubMed ID: 15069692
[TBL] [Abstract][Full Text] [Related]
44. Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.
Ashton LJ; Murray JE; Haber M; Marshall GM; Ashley DM; Norris MD
Pharmacogenet Genomics; 2007 Sep; 17(9):709-17. PubMed ID: 17700360
[TBL] [Abstract][Full Text] [Related]
45. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
Suzuki S; Muroishi Y; Nakanishi I; Oda Y
J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
[TBL] [Abstract][Full Text] [Related]
46. Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression.
Duarte EC; Ribeiro DC; Gomez MV; Ramos-Jorge ML; Gomez RS
Anticancer Res; 2008; 28(2A):1101-6. PubMed ID: 18507060
[TBL] [Abstract][Full Text] [Related]
47. Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma.
Gallou C; Longuemaux S; Deloménie C; Méjean A; Martin N; Martinet S; Palais G; Bouvier R; Droz D; Krishnamoorthy R; Junien C; Béroud C; Dupret JM
Pharmacogenetics; 2001 Aug; 11(6):521-35. PubMed ID: 11505222
[TBL] [Abstract][Full Text] [Related]
48. A cross-sectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes.
Schnakenberg E; Fabig KR; Stanulla M; Strobl N; Lustig M; Fabig N; Schloot W
Environ Health; 2007 Feb; 6():6. PubMed ID: 17291352
[TBL] [Abstract][Full Text] [Related]
49. Association between polymorphisms in xenobiotic detoxification-related genes with prognosis of epithelial ovarian cancer.
Carron J; Brito AB; Torelli AC; Oliveira C; Derchain SF; Lima CS; Lourenço GJ
Med Oncol; 2016 Oct; 33(10):112. PubMed ID: 27586145
[TBL] [Abstract][Full Text] [Related]
50. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
[TBL] [Abstract][Full Text] [Related]
51. [POLYMORPHISM OF GLUTHATIONE-S-TRANSFERASE P1 IN CHILDREN WITH REFLUX-ESOPHAGITIS].
Zagorskiy SE; Melnov SB; Sinevich EA
Lik Sprava; 2015; (1-2):134-5. PubMed ID: 26118046
[TBL] [Abstract][Full Text] [Related]
52. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
Mota P; Silva HC; Soares MJ; Pego A; Loureiro M; Cordeiro CR; Regateiro FJ
J Cancer Res Clin Oncol; 2015 May; 141(5):851-60. PubMed ID: 25388590
[TBL] [Abstract][Full Text] [Related]
53. Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer.
Ferraz JM; Zinzindohoué F; Lecomte T; Cugnenc PH; Loriot MA; Beaune P; Stücker I; Berger A; Laurent-Puig P
Int J Cancer; 2004 Jun; 110(2):183-7. PubMed ID: 15069679
[TBL] [Abstract][Full Text] [Related]
54. Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.
Kim HN; Kim NY; Yu L; Kim YK; Lee IK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
Am J Hematol; 2009 Dec; 84(12):821-5. PubMed ID: 19899130
[TBL] [Abstract][Full Text] [Related]
55. Polymorphisms of NAT2, CYP2E1, GST, and HLA related to drug-induced liver injury in indonesian tuberculosis patients.
Perwitasari DA; Darmawan E; Mulyani UA; Vlies PV; Alffenaar JC; Atthobar J; Wilffert B
Int J Mycobacteriol; 2018; 7(4):380-386. PubMed ID: 30531039
[TBL] [Abstract][Full Text] [Related]
56. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
Watanabe M
Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
[TBL] [Abstract][Full Text] [Related]
57. Polymorphisms within glutathione S-transferase genes in pediatric non-Hodgkin's lymphoma.
Dieckvoss BO; Stanulla M; Schrappe M; Beier R; Zimmermann M; Welte K; Reiter A
Haematologica; 2002 Jul; 87(7):709-13; discussion 713. PubMed ID: 12091121
[TBL] [Abstract][Full Text] [Related]
58. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Sarmanová J; Benesová K; Gut I; Nedelcheva-Kristensen V; Tynková L; Soucek P
Hum Mol Genet; 2001 Jun; 10(12):1265-73. PubMed ID: 11406608
[TBL] [Abstract][Full Text] [Related]
59. Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients.
Kilburn L; Okcu MF; Wang T; Cao Y; Renfro-Spelman A; Aldape KD; Gilbert MR; Bondy M
Cancer; 2010 May; 116(9):2242-9. PubMed ID: 20187096
[TBL] [Abstract][Full Text] [Related]
60. Genetic polymorphisms in metabolic enzymes and susceptibility to anti-tuberculosis drug-induced hepatic injury.
Feng FM; Guo M; Chen Y; Li SM; Zhang P; Sun SF; Zhang GS
Genet Mol Res; 2014 Nov; 13(4):9463-71. PubMed ID: 25501156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
